Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment.

P921

Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment.

Item

http://www.wikidata.org/entity/Q36183227

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patient preferences for treatm ...... a discrete-choice experiment.

@ast

Patient preferences for treatm ...... a discrete-choice experiment.

@en

type

Item

label

Patient preferences for treatm ...... a discrete-choice experiment.

@ast

Patient preferences for treatm ...... a discrete-choice experiment.

@en

prefLabel

Patient preferences for treatm ...... a discrete-choice experiment.

@ast

Patient preferences for treatm ...... a discrete-choice experiment.

@en

P1433

Q36183227-0D777194-EB32-4A72-A464-3D61D8286309

P1476

Q36183227-9670C47F-2269-4FD4-A2BE-65E7A9DDABA3

P2093

Q36183227-2DB731D2-5990-41DF-8280-F014A399C599

Q36183227-33EBF467-A817-43C7-9B5C-E4EDF5DC95FA

Q36183227-67E027BB-BB6B-434E-9539-4735F96BF3F2

Q36183227-6B90A96C-5AB8-4F57-8B83-5616397DE146

Q36183227-82175A96-EA9D-4C0A-899F-D2A235F7B69A

Q36183227-888B79EE-5049-476E-BCC9-14E01F904704

Q36183227-8AAFEDC2-FD65-4895-8A2B-D37AFB5DB6F0

Q36183227-913E912D-3F82-4197-ABA0-8586CFA2DADA

Q36183227-973864CA-B2CF-4633-AEBC-953725DFF2E7

Q36183227-A5964F9E-ED0F-4EA5-9178-6D3A12438404

P2507

Q36183227-8DF879D0-B315-46A8-AC54-0DBA0031C316

P2860

Q36183227-010B126B-3B17-4A4B-8FF2-BA48F5C52446

Q36183227-185C4579-DB06-4BD9-B282-C44CDA48CBE8

Q36183227-19DB82A4-1F08-4EC6-8BA2-DEAB9E00B5A3

Q36183227-2FA93C85-D581-4B0A-8001-4FFA156613FC

Q36183227-422D4BAC-3679-43B9-AA73-A8F5475A637E

Q36183227-4A2B0589-8F5F-47D0-8FC8-6F7A7C561BC0

Q36183227-4D56F430-EF50-4057-8D62-31C89F8DE8E0

Q36183227-6F7D3F57-545A-4C4B-B745-CA1BCFD54D83

Q36183227-750BB265-9E69-4E68-ADB1-F46EAA6A9687

Q36183227-7B086896-9970-4102-9359-A5F833F16EAF

P304

Q36183227-017D06CE-093D-4B0B-80FB-2831D91F6925

P31

Q36183227-BD4ED829-D9DC-4629-9872-BA842C12C993

P356

Q36183227-F336A779-DEBA-4BD1-8493-042164761B61

P433

Q36183227-A1B0F512-9A0B-4933-A5C5-8C0573085708

P478

Q36183227-23A50CF0-A6EF-4241-AC3D-B8FD4AC2B46E

P50

Q36183227-47B970C4-3758-4921-A564-A6B84321B484

P577

Q36183227-5A50C5D1-2DA0-4445-AC64-9F470E0F860C

P698

Q36183227-78D1FA32-E105-463B-AA2E-FFF7634D24FF

P932

Q36183227-AB90434A-9AF0-4D11-8E26-D1CBE8486AF0

P356

S12894-016-0182-2

P1433

BMC Urology

P1476

Patient preferences for treatm ...... a discrete-choice experiment.

@en

P2093

Akito Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Ateesha F Mohamed

http://www.w3.org/2001/XMLSchema#string

Aya Narimatsu

http://www.w3.org/2001/XMLSchema#string

Dianne Athene Ledesma

http://www.w3.org/2001/XMLSchema#string

Ed Wang

http://www.w3.org/2001/XMLSchema#string

Enrique Basurto

http://www.w3.org/2001/XMLSchema#string

Hiroji Uemura

http://www.w3.org/2001/XMLSchema#string

Ian McKinnon

http://www.w3.org/2001/XMLSchema#string

Kristen Concialdi

http://www.w3.org/2001/XMLSchema#string

Marco DiBonaventura

http://www.w3.org/2001/XMLSchema#string

P2507

Erratum to: Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment.

P2860

Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Alpha emitter radium-223 and survival in metastatic prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Enzalutamide in metastatic prostate cancer before chemotherapy.

A phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapy.

Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.

Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12894-016-0182-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Go Kimura

P577

2016-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27814714

http://www.w3.org/2001/XMLSchema#string

P932

5095997

http://www.w3.org/2001/XMLSchema#string